Skip to main content

Animations

MJFF Publications

4831 - 4840 of 6422 Results
Title
Year
  • Year
  • 2021
  • 2020
  • 2024
  • 2018
  • 2016
  • 2017
  • 2017
  • 2024
  • 2022
  • 2015
  • Summary Details
    OPEN
    Title: T-cell based immunotherapies for Parkinson’s disease
    Journal Name: Exploration of Neuroprotective Therapy
    Publisher: Open Exploration Publishing
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.37349/ent.2021.00007
    Citation Count: 11
  • Summary Details
    OPEN
    Title: α-Synuclein-specific T cell reactivity is associated with preclinical and early Parkinson’s disease
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41467-020-15626-w
    Citation Count: 341
  • Summary Details
    OPEN
    Title: The Black and African American Connections to Parkinson’s Disease (BLAAC PD) study protocol
    Journal Name: BMC Neurology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1186/s12883-024-03914-7
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Myosin VI-Dependent Actin Cages Encapsulate Parkin-Positive Damaged Mitochondria
    Journal Name: Developmental Cell
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1016/j.devcel.2018.01.007
    Citation Count: 101
  • Summary Details
    OPEN
    Title: Subcortical Volumes Differ in Parkinson’s Disease Motor Subtypes: New Insights into the Pathophysiology of Disparate Symptoms
    Journal Name: Frontiers in Human Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnhum.2016.00356
    Citation Count: 56
  • Summary Details
    OPEN
    Title: Longitudinal assessment of excessive daytime sleepiness in early Parkinson’s disease
    Journal Name: Journal of Neurology, Neurosurgery & Psychiatry
    Publisher: BMJ
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1136/jnnp-2016-315023
    Citation Count: 100
  • Summary Details
    OPEN
    Title: Quantitative proteomics identifies altered O‐GlcNAcylation of structural, synaptic and memory‐associated proteins in Alzheimer's disease
    Journal Name: The Journal of Pathology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/path.4929
    Citation Count: 127
  • Summary Details
    OPEN
    Title: Team Science Approaches to Unravel Monogenic Parkinson's Disease on a Global Scale
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1002/mds.29925
    Citation Count: 5
  • Summary Details
    OPEN
    Title: Epidemiology meets toxicogenomics: Mining toxicologic evidence in support of an untargeted analysis of pesticides exposure and Parkinson’s disease
    Journal Name: Environment International
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.envint.2022.107613
    Citation Count: 14
  • Summary Details
    OPEN
    Title: Design, Synthesis, and Characterization of 3-(Benzylidene)indolin-2-one Derivatives as Ligands for α-Synuclein Fibrils
    Journal Name: Journal of Medicinal Chemistry
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1021/acs.jmedchem.5b00571
    Citation Count: 107
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.